Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
about
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivinTumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsNuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferaseNegative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1bAllele-specific amplification in cancer revealed by SNP array analysisPosttranscriptional regulation of cancer traits by HuRThe Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformationA multilevel data integration resource for breast cancer study.eQTL Mapping Using RNA-seq DataRelevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphomaThe influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover.Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibilitySLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.The CCND1 G870A polymorphism and susceptibility to bladder cancer.A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.Highly expressed UNC119 promotes hepatocellular carcinoma cell proliferation through Wnt/β-catenin signaling and predicts a poor prognosisAssociation Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-AnalysisTransvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.Anti cancer effects of curcumin: cycle of life and death.PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone RegulationExamining the role of cyclin D1 in breast cancer.Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.Differential expression analysis by gene array of cell cycle modulators in human corneal epithelial cells stimulated with epidermal growth factor (EGF), hepatocyte growth factor (HGF), or keratinocyte growth factor (KGF).Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells.Gambogic Acid and Its Role in Chronic Diseases.Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation.Quantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cells.Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.The Akt pathway in human breast cancer: a tissue-array-based analysis.Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.
P2860
Q21195209-351D9C20-28F8-4957-A354-23F2EA0DA325Q21562666-D4087C89-9DC9-4C81-87CF-67BBF41AAA71Q24303548-02D79C6A-475B-437F-B46C-D358B6857519Q24535621-39919733-95D9-45D1-92C1-DB7BD59033ECQ24610494-ECD35C11-F2CC-4EFD-B2CD-FB84877D4EBCQ24811573-0C0CFCD6-A920-48AA-991B-5EBC28E56FFEQ28248667-6F5FB57D-75C6-4983-929E-CD1E3CEE3524Q28592198-AD0CBB8E-A02B-4EF3-B493-FA459D0D348EQ30390024-694ABCD1-66CD-4947-9F2E-BEF22855005DQ30625155-351154CA-E46D-4452-9BE4-A76524509B88Q33259459-8C172730-CC53-4809-8F96-1C07B2455D3AQ33372463-62B0CD15-1192-4544-8D27-1BF2D0BDEE64Q33966174-A4A2C39B-CE7D-4CB5-A1E4-A2E703F454C4Q34346963-F5EA6C78-CB06-4AEE-8B7A-3CA158F92045Q34452617-6ECEB9F2-A070-448B-8FA5-C06FDFBB6021Q34733433-B2C21FB8-00C1-404E-8773-57605B0B0D3DQ34871503-2A43CF8E-682A-416D-A65F-D3304F12431AQ35099578-27246F7A-EE6D-4354-A7DD-158A467ACDA5Q36309407-E3DE9DD3-7A63-46EC-A10C-352F410DE7FAQ36702703-0D363FBE-8C40-4743-8B36-BA85A6E12C78Q36851904-0ED8C9AD-5A4F-4369-81E4-0273ED9433A0Q37286351-58B87AFC-DD15-4C04-82CD-2928E1B778B5Q37290922-31275661-E208-416A-812A-CA5FAF3DA750Q37698862-A68522E0-D543-4FC0-889F-EBC53B745558Q37889965-E669140E-CA95-4E21-A7A5-5D655B2AB8D5Q38175443-B7590796-61A9-4BD4-8BF7-3989B9161E62Q38292470-AAD66362-787C-4E68-A18C-E890C2A58E7AQ38452330-0C5C2979-CB4E-42F6-83DF-853339A56FBBQ38721364-A86183AB-E793-4E74-8417-149B1E067E91Q38965229-35F0DA99-A601-4985-BA5D-ABF6C19AAC21Q40027619-770992E6-0918-4449-9510-0557562A65D8Q40302213-DA95652E-AED9-4A74-8A6F-DD6F2EE760C9Q41812307-4F6AD8EC-DEE6-4248-A8E0-445D1B719162Q42775929-34325D82-8B58-4319-B36C-A1CB85C7BC00Q42801826-8CA98A7C-AF58-49AE-8C81-61ADE3BC127BQ43709177-080A7CEC-5B26-4475-B498-1EBF968817FDQ45015104-8C7B8151-C858-4B3E-AE03-A5C448EFB502Q46845226-058CF845-F100-4555-B1AD-94FFC98D6698Q47151248-46660C6F-331D-4532-A36E-DDADDC2F6EF9Q47932543-3BCF9DE4-5436-48F8-8862-E73C1B894236
P2860
Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Mechanism of cyclin D1 (CCND1, ...... of allele-specific expression.
@en
type
label
Mechanism of cyclin D1 (CCND1, ...... of allele-specific expression.
@en
prefLabel
Mechanism of cyclin D1 (CCND1, ...... of allele-specific expression.
@en
P2860
P1476
Mechanism of cyclin D1 (CCND1, ...... of allele-specific expression.
@en
P2093
P2860
P356
10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5
P577
1998-05-01T00:00:00Z